Yuki Gosei Kogyo Co., Ltd. (JP:4531)
:4531
Want to see JP:4531 full AI Analyst Report?
4531 Stock Chart & Stats
¥317.00
¥0.00(0.00%)
At close: 4:00 PM EST
¥317.00
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥260.00 - ¥640.00
Previous CloseN/A
Volume43.40K
Average Volume (3M)39.67K
Market Cap
¥8.97B
Enterprise Value¥13.05B
Total Cash (Recent Filing)¥1.05B
Total Debt (Recent Filing)¥9.06B
Price to Earnings (P/E)28.3
Beta1.13
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.97%
Share Statistics
EPS (TTM)N/A
Shares Outstanding21,974,000
10 Day Avg. Volume32,460
30 Day Avg. Volume39,673
Financial Highlights & Ratios
PEG Ratio-0.41
Price to Book (P/B)0.62
Price to Sales (P/S)0.55
P/FCF Ratio4.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance-sheet StabilityA consistently positive equity base with moderate historical leverage provides financial flexibility to absorb cyclical volatility and fund R&D or capex without immediate refinancing. This structural balance-sheet strength supports long-term resilience across business cycles.
Recent Cash-flow RecoveryThe material reversal to strong operating cash flow and positive free cash flow in 2026 indicates the business can generate internal funding when execution aligns with demand. Sustained cash generation improves ability to pay down debt, invest in specialty capabilities and support dividends.
Diversified Specialty-chemicals End MarketsExposure to multiple end markets—pharma intermediates, agricultural chemicals and industrial materials—reduces revenue concentration risk. The company's specialty-chemical focus and tailored solutions create sticky customer relationships and structural demand across sectors.
Bears Say
Earnings Volatility / 2026 Profit DropA sharp year-over-year earnings decline signals margin pressure or one-off costs that weakened profitability. Persistent volatility in net income undermines planning, makes investment and dividend policies less predictable, and raises execution risk for multi-year strategy.
Multi-year Inconsistent Free Cash FlowHistoric periods of negative free cash flow indicate the company struggled to internally fund investment needs and operations. Until strong 2026 cash generation proves durable, past cash burn reduces confidence in funding flexibility and increases refinancing or capital-raising risk.
Rising Debt And Leverage RiskAn increase in absolute debt levels, even with moderate leverage ratios, raises fixed-cost obligations and vulnerability if profitability weakens. Elevated debt constrains strategic optionality and heightens financial risk during continued earnings softness.
Yuki Gosei Kogyo Co., Ltd. News
4531 FAQ
What was Yuki Gosei Kogyo Co., Ltd.’s price range in the past 12 months?
Yuki Gosei Kogyo Co., Ltd. lowest stock price was ¥260.00 and its highest was ¥640.00 in the past 12 months.
What is Yuki Gosei Kogyo Co., Ltd.’s market cap?
Yuki Gosei Kogyo Co., Ltd.’s market cap is ¥8.97B.
When is Yuki Gosei Kogyo Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Yuki Gosei Kogyo Co., Ltd.’s earnings last quarter?
Currently, no data Available
Is Yuki Gosei Kogyo Co., Ltd. overvalued?
According to Wall Street analysts Yuki Gosei Kogyo Co., Ltd.’s price is currently Overvalued.
Does Yuki Gosei Kogyo Co., Ltd. pay dividends?
Yuki Gosei Kogyo Co., Ltd. pays a Annually dividend of ¥9.922 which represents an annual dividend yield of 2.97%. See more information on Yuki Gosei Kogyo Co., Ltd. dividends here
What is Yuki Gosei Kogyo Co., Ltd.’s EPS estimate?
Yuki Gosei Kogyo Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yuki Gosei Kogyo Co., Ltd. have?
Yuki Gosei Kogyo Co., Ltd. has 21,974,000 shares outstanding.
What happened to Yuki Gosei Kogyo Co., Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Yuki Gosei Kogyo Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4531
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yuki Gosei Kogyo Co., Ltd.
Yuki Gosei Kogyo Co., Ltd. is a Japanese enterprise that globally researches, develops, produces, and markets sophisticated fine chemical products. Their diverse portfolio encompasses food-grade additives, pharmaceutical components, and chemicals for industrial and agricultural applications. Key offerings include glycine and its derivatives, nicotinamide, isoniazid, various drug intermediates, and cosmetic raw materials. The company also provides a range of specialized compounds, such as those based on amino acids, pyridine, piperidine, and silicon, alongside biological products like DNA, nucleosides, protamine, and active pharmaceutical ingredients (APIs). Furthermore, they offer contract manufacturing services for pharmaceutical and chemical products. Established in 1947, Yuki Gosei Kogyo Co., Ltd. is headquartered in Tokyo, Japan.
Technical Analysis
NANKAI CHEMICAL COMPANY LIMITED
―
Nippon Soda Co., Ltd.
―
Toho Acetylene Co., Ltd.
―
Daito Chemix Corporation
―
Toyo Gosei Co., Ltd.
―